Xanya Sofra-Weiss, Ph.D
A clinical study with individuals presenting abnormally clumped Red Blood Cells’ (RBCs) was completed in February 2009 with the Ion Magnum. Results indicate that this technology rapidly and efficiently leads to normalized erythrocytes’ separation at the microscopic level. RBCs separation is crucial for the overall blood flow and timely transport of hormones, antibodies, oxygen and nutrients to the cells, and waste products to the kidneys. Ion Magnum’s (IM) dynamic, multi-sine, analogue waveform was originally tested at the cellular level by Dr. Donald Gilbert, a molecular biologist, in the eighties. After 30 years of research, the Ion Magnum was electronically engineered by the Co-Inventor of the first Pacemaker (2008) to resonate the motor nerve’s signal of strenuous exercise normally emitted by the brain. Due to its resonance with the biological signal, the Ion Magnum signal spreads throughout the CNS inducing effortless and painless isometric and isotonic muscle contractions. The signal to the nerve ultimately triggers hormonal secretion such as Growth Hormone (GF), Thyroxine (T4) and Triiodothyronine (T3) for lipolysis and Insulin Growth Factor (IGF-1) formuscle hypertrophy.
CONCLUSION: The results of this clinical microscopy study are summarized:
1. Ion Magnum (IM) treatments result in an overall improvement in terms of normalized erythrocyte separation.
2. On the average, RBCs separation appears to linearly improve with increased number of Ion Magnum treatments.
3. Ion Magnum treatments appear to have a negative correlation with the number of fungal forms, poikilocytosis, thrombocyte aggregation and bacteria present in the blood prior to the IM treatments, demonstrating a significant reduction of all of the above mentioned variables.
4. The enhanced erythrocyte separation as well as the reduction of fungal forms, poikilocytosis, thrombocyte aggregation and bacteria persisted during the intervals between treatments. A longitudinal study is necessary to investigate the total length of time during which such normalization effects continue to be present. So far, two subjects that have been followed up over a period of three months have sustained the Ion Magnum’s positive effects on RBCs separation. This technology that was initially based on research associated with the Pacemaker and gained its popularity in the field of body building and cosmetic procedures is now coming full circle by offering benefits that can be potentially used in Medicine to reduce the incidence or progression of cardiac disorders resulting from erythrocyte aggregation. IM treatments effortlessly exercise the body without lactic acid production while enhancing RBCs separation. This process of exercising without actually exercising could solve the dilemma caused by intolerance to Statins which is associated with intolerance to exercise, possibly due to lactic acid formation. Statins are widely prescribed to lower high blood cholesterol and thus reduce the risk for heart disease.
Xanya Sofra Weiss
No comments:
Post a Comment